Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BCTX | US
0.11
2.48%
Healthcare
Biotechnology
30/04/2024
09/04/2026
4.54
4.33
4.61
4.33
BriaCell Therapeutics Corp. an immuno-oncology-focused biotechnology company engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to conduct preclinical studies to develop and test Bria-OTS cellular immunotherapy as a treatment for cancer. BriaCell Therapeutics Corp. is based in West Vancouver Canada.
View LessHigh 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
67.4%1 month
78.3%3 months
156.0%6 months
139.7%-
-
17.03
-
-
-1.38
-
-
-35.25M
162.93M
162.93M
-
-
-
-
-206.01
0.04
1.56
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.90
Range1M
0.90
Range3M
8.50
Rel. volume
1.00
Price X volume
928.64K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| OABI | OABI | Biotechnology | 1.5 | 177.24M | -1.32% | n/a | 8.27% |
| Caribou Biosciences Inc. | CRBU | Biotechnology | 1.96 | 177.11M | 0.51% | n/a | 8.80% |
| Bolt Technology Corp | BOLT | Biotechnology | 4.51 | 172.57M | -1.96% | n/a | 22.00% |
| Codexis Inc | CDXS | Biotechnology | 2.4 | 170.23M | 8.60% | n/a | 69.22% |
| Adagene Inc. | ADAG | Biotechnology | 3.845 | 170.22M | -3.88% | n/a | 36.29% |
| Immuneering Corporation Class A Common Stock | IMRX | Biotechnology | 5.66 | 167.84M | 2.91% | n/a | 6.50% |
| Protalix BioTherapeutics Inc | PLX | Biotechnology | 2.28 | 167.68M | 1.33% | n/a | 91.50% |
| Nkarta Inc | NKTX | Biotechnology | 2.34 | 165.11M | 1.30% | n/a | 18.88% |
| ProQR Therapeutics N.V | PRQR | Biotechnology | 1.98 | 161.73M | 8.20% | n/a | 53.73% |
| OBIO | OBIO | Biotechnology | 4.23 | 160.00M | -0.94% | n/a | 3.29% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 10.17 | 163.30M | 1.09% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.1 | 97.93M | -1.76% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 5.52 | 89.92M | -2.82% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.62 | 72.76M | -1.53% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.55 | 64.11M | 4.41% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.16 | 16.95M | -4.13% | 0.03 | 16.03% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 11.02 | 16.78M | 94.36% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.651 | 12.58M | -0.82% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3 | 3.32M | 2.85% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2987 | 2.84M | 10.96% | n/a | 19.98% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.38 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 17.03 | 15.55 | Par |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 156.05 | - | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 162.93M | - | Emerging |